CHRW monthly performance report
Explore CHRW's monthly returns, drawdown, and seasonality trends — updated every month.
CHRW monthly report
—
Key takeaways
- C.H. Robinson (CHRW) closed November 2026 at $134.46, up 7.90% for the month and −11.34% over the trailing 12 months.
- Year-to-date, CHRW is −16.36%, underperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading −19.75% versus its 200-day moving average ($167.54), a cautious technical signal.
- Over the past three years, CHRW has underperformed the S&P 500 by −1.11%, with a relative strength index reading of 99.4.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
C.H. Robinson ended November 2026 at $134.46, posting a monthly return of +7.90%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +8.08%.
The current quarter stands at −9.12% (Q4 2026 (QTD)), while medium-term trend remains soft: price is −19.75% versus the 200-day moving average ($167.54).
Year-to-date, CHRW is −16.36% against SPY +10.62%, a gap of −26.98%. The stock is currently −36.07% below its 52-week high, with maximum 3-year drawdown at −40.50%.
| Period | CHRW | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.05% | −0.36% | +0.42% |
| 1 Week | +7.28% | +2.59% | +4.69% |
| 1 Month | +7.90% | −0.18% | +8.08% |
| 3 Months | −9.97% | −2.37% | −7.60% |
| 6 Months | −19.59% | +0.83% | −20.41% |
| YTD | −16.36% | +10.62% | −26.98% |
| 12 Months | −11.34% | +12.25% | −23.59% |
| 3 Years | +70.27% | +71.37% | −1.11% |
| Rank | Month | Return |
|---|---|---|
| #1 | May 2024 | +21.65% |
| #2 | Jan 2026 | +21.27% |
| #3 | Jul 2025 | +20.19% |
| #4 | Oct 2025 | +16.31% |
| #5 | Aug 2024 | +16.24% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | −21.56% |
| #2 | Oct 2026 | −15.78% |
| #3 | Apr 2025 | −12.87% |
| #4 | Feb 2024 | −11.90% |
| #5 | Mar 2026 | −10.35% |
| Quarter | Return |
|---|---|
| Q3 2025 | +37.99% |
| Q4 2025 | +21.42% |
| Q1 2026 | +3.30% |
| Q2 2026 | +13.41% |
| Q3 2026 | −21.44% |
| Q4 2026 (QTD) | −9.12% |
| Year | Return |
|---|---|
| 2023 | −5.65% |
| 2024 | +19.60% |
| 2025 | +55.59% |
| 2026 | −16.36% |
| Metric | Value |
|---|---|
| 52-Week High | $210.33 (2026-07-22) |
| 52-Week Low | $122.21 (2026-10-30) |
| Current Price | $134.46 |
| 200-Day Moving Average | $167.54 |
| Price vs 200DMA | −19.75% |
| 3-Year Maximum Drawdown | −40.50% (2026-10-30) |
| Current Drawdown from 52W High | −36.07% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 99.4 |
| 3-Year Excess Return vs S&P 500 | −1.11% |
| RS Peak | 162.4 (Feb 2026) |
| RS Trough | 75.2 (Apr 2024) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CHRW's return for this report period?
CHRW returned +7.90% in the latest monthly window ending 2026-11-13.
Has CHRW outperformed SPY year to date?
YTD CHRW: −16.36% vs SPY: +10.62%.
What is CHRW's 12-month return?
−11.34% over the trailing 12 months.
Is CHRW above or below its 200-day moving average?
Price is −19.75% versus 200DMA ($167.54).
What is the maximum drawdown in the 3-year window?
−40.50% on 2026-10-30.